Gilead Sciences, Inc. (GILD): A Bull Case Theory

We came across a bullish thesis on Gilead Sciences, Inc. on Dividend Talks’s Substack. In this article, we will summarize the bulls’ thesis on GILD. Gilead Sciences, Inc.’s share was trading at $110.87 as of June 30th. GILD’s trailing and forward P/E were 23.29 and 14.01 respectively according to Yahoo Finance.

A doctor holding a vial of medication related to antiviral treatments in a medical office.

Gilead Sciences (GILD) is a leading biopharmaceutical company known for its...